JP2023543493A5 - - Google Patents
Info
- Publication number
- JP2023543493A5 JP2023543493A5 JP2023519819A JP2023519819A JP2023543493A5 JP 2023543493 A5 JP2023543493 A5 JP 2023543493A5 JP 2023519819 A JP2023519819 A JP 2023519819A JP 2023519819 A JP2023519819 A JP 2023519819A JP 2023543493 A5 JP2023543493 A5 JP 2023543493A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- ids
- antibody
- antigen
- sequence numbers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020119648 | 2020-09-30 | ||
| CNPCT/CN2020/119648 | 2020-09-30 | ||
| CN2021072534 | 2021-01-18 | ||
| CNPCT/CN2021/072534 | 2021-01-18 | ||
| PCT/CN2021/121585 WO2022068854A1 (en) | 2020-09-30 | 2021-09-29 | Antibodies targeting human claudin 18.2 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543493A JP2023543493A (ja) | 2023-10-16 |
| JP2023543493A5 true JP2023543493A5 (https=) | 2024-09-24 |
Family
ID=80949747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519819A Pending JP2023543493A (ja) | 2020-09-30 | 2021-09-29 | ヒトクローディン１８．２を標的とする抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240034784A1 (https=) |
| EP (1) | EP4222174A4 (https=) |
| JP (1) | JP2023543493A (https=) |
| KR (1) | KR20230078701A (https=) |
| CN (1) | CN116390953A (https=) |
| WO (1) | WO2022068854A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024137619A1 (en) | 2022-12-20 | 2024-06-27 | Bolt Biotherapeutics, Inc. | Anti-claudin, bis-benzimid azole sting agonist immunoconjugates, and uses thereof |
| WO2024173384A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| WO2026050214A1 (en) | 2024-08-27 | 2026-03-05 | Bolt Biotherapeutics, Inc. | Anti-claudin, tlr agonist immunoconjugates and uses thereof |
| WO2026076388A1 (en) * | 2024-10-03 | 2026-04-09 | The Broad Institute, Inc. | Vhh polypeptides that bind to claudin-18, compositions and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2979068T3 (es) * | 2016-07-08 | 2024-09-24 | Crage Medical Co Ltd | Anticuerpos para anti-claudina 18A2 y utilización de los mismos |
| CA3177692A1 (en) * | 2017-02-27 | 2018-08-30 | Dragonfly Therapeutics, Inc. | Multispecific binding proteins targeting caix, ano1, mesothelin, trop2, or claudin-18.2 |
| CN110606891B (zh) * | 2018-06-17 | 2022-12-06 | 上海健信生物医药科技有限公司 | 一种针对人cldn18.2的抗体分子，抗原结合片段及其医药用途 |
| JP7513605B2 (ja) * | 2018-07-18 | 2024-07-09 | アスクジーン・ファーマ・インコーポレイテッド | 新規な抗体ならびにそれを調製および使用するための方法 |
| BR112021011014A2 (pt) * | 2018-12-07 | 2021-08-31 | Zlip Holding Limited | Anticorpos anti-claudina e usos destes |
| CN111434692B (zh) * | 2019-01-15 | 2021-12-31 | 浙江道尔生物科技有限公司 | 抗cld18a2纳米抗体及其应用 |
| CN109762067B (zh) * | 2019-01-17 | 2020-02-28 | 北京天广实生物技术股份有限公司 | 结合人Claudin 18.2的抗体及其用途 |
-
2021
- 2021-09-29 WO PCT/CN2021/121585 patent/WO2022068854A1/en not_active Ceased
- 2021-09-29 JP JP2023519819A patent/JP2023543493A/ja active Pending
- 2021-09-29 US US18/245,114 patent/US20240034784A1/en active Pending
- 2021-09-29 KR KR1020237012580A patent/KR20230078701A/ko active Pending
- 2021-09-29 EP EP21874509.9A patent/EP4222174A4/en active Pending
- 2021-09-29 CN CN202180067435.6A patent/CN116390953A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023543493A5 (https=) | ||
| JP2022512132A5 (https=) | ||
| JP2025163055A5 (https=) | ||
| JP2023509196A5 (https=) | ||
| JP2022093564A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| JP2022506072A5 (https=) | ||
| JP2021510521A5 (https=) | ||
| JP2019533719A5 (https=) | ||
| JP2020531043A5 (https=) | ||
| JP2013502913A5 (https=) | ||
| JP2019501883A5 (https=) | ||
| JP2010509931A5 (https=) | ||
| JP2011207882A5 (https=) | ||
| JP2026041845A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2020522488A5 (https=) | ||
| JP2023540526A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| CN115461373A (zh) | 密蛋白18.2的抗体及其用途 | |
| US20230071019A1 (en) | Compositions and methods for reducing off-target toxicity of antibody drug conjugates |